MTOR and cancer: Additionally, using a combination treatment of metformin and 2DG significantly inhibited the mTOR pathway, decreased the levels of cell-cycle-related proteins and inhibited cell proliferation and migration and thus could prove to be a potential anti-proliferative and anti-angiogenic therapeutic strategy in the treatment of several cancers.